Generic Name and Formulations:
Caprylic triglyceride, potassium caseinate (milk-derived protein), maltodextrin, whey protein (milk-derived), sugar, sunflower oil, dimagnesium phosphate, tricalcium phosphate, dipotassium phosphate, soy lecithin, distilled monoglyceride, silicon dioxide, natural vanilla bean extract, sucralose, acesulfame potassium; pwd; 40g per packet.
Indications for AXONA:
Dietary management of the metabolic processes associated with mild to moderate Alzheimer's disease.
1 packet once daily after meals; add contents of packet in 4–8oz of water or preferred liquids, mix thoroughly. May start with a graduated dosing regimen for 7 days before taking one full packet per day.
Milk or soy allergy.
Risk of ketoacidosis (eg, alcoholics, poorly controlled diabetics). History of GI inflammatory conditions (eg, IBS, diverticular disease, chronic gastritis, severe GERD). Renal dysfunction. Monitor triglyceride levels during therapy.
GI upset, flatulence, dyspepsia, dizziness, headache, increases in BUN, uric acid, or creatinine.
Endocrinology Advisor Articles
- Subclinical Hypothyroidism: Controversies in Testing and Treatment
- Favorable Outcomes With Second-Generation Insulin Analogs in Type 2 Diabetes
- Canagliflozin Trial for T2D With CKD Stopped Early Due to Positive Results
- Type 2 Diabetes and Alzheimer Disease: What's the Connection?
- Risk for Hypoglycemia During Titration With Insulin Glargine 100 U/mL in T2D
- Using Latent Class Trajectory Analysis to Determine Glucose Response Curve Patterns
- First CGM System With Implantable Glucose Sensor Approved
- Empagliflozin, Linagliptin Combination Therapy vs Linagliptin Monotherapy for Type 2 Diabetes
- Risk for Below Knee Amputations With Canagliflozin vs Other Antihyperglycemic Agents
- Two Phases of C-Peptide Decline Identified in Type I Diabetes
- Effect of SGLT2 Inhibitors on Heart Failure-Related Hospitalization, Below-Knee Amputation
- Nutraceuticals Containing Equol May Be Effective for Postmenopausal Symptoms
- Conservative Monitoring Strategy for Non-Functioning Pituitary Adenomas Evaluated
- FDA: Some Rx Drugs May Become Available Without Seeing a Doctor
- PM2.5 Contributes to Burden of Diabetes Mellitus Globally